Stay updated on BBI608 Pembrolizumab Combination: Clinical Trial
Sign up to get notified when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.

Latest updates to the BBI608 Pembrolizumab Combination: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new page revision tag v3.4.2 is added and a previous funding notice about government operating status is removed. No study content, results, eligibility criteria, enrollment numbers, or navigation elements are altered.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and a version update to v3.4.1 were added; the previous version was v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedShow glossary was added; metadata labels were updated (Last Update Submitted that Met QC Criteria and No FEAR Act Data) with Revision: v3.4.0 to replace v3.3.4. These changes are editorial and UI-focused and do not modify study data, eligibility criteria, or core functionality.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a Locations section with Chiba; removed HHS Vulnerability Disclosure and Chiba Locations; page revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. No core content or study details were modified.SummaryDifference0.1%

- Check99 days agoChange DetectedThe warning banner about potential data updates due to a lapse in government funding was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to BBI608 Pembrolizumab Combination: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Pembrolizumab Combination: Clinical Trial page.